839 related articles for article (PubMed ID: 22319034)
21. The incretin effect in Korean subjects with normal glucose tolerance or type 2 diabetes.
Oh TJ; Kim MY; Shin JY; Lee JC; Kim S; Park KS; Cho YM
Clin Endocrinol (Oxf); 2014 Feb; 80(2):221-7. PubMed ID: 23405851
[TBL] [Abstract][Full Text] [Related]
22. The effect of 8 days of strict bed rest on the incretin effect in healthy volunteers.
Nielsen ST; Harder-Lauridsen NM; Benatti FB; Wedell-Neergaard AS; Lyngbæk MP; Møller K; Pedersen BK; Krogh-Madsen R
J Appl Physiol (1985); 2016 Mar; 120(6):608-14. PubMed ID: 26679616
[TBL] [Abstract][Full Text] [Related]
23. Predictors of incretin concentrations in subjects with normal, impaired, and diabetic glucose tolerance.
Vollmer K; Holst JJ; Baller B; Ellrichmann M; Nauck MA; Schmidt WE; Meier JJ
Diabetes; 2008 Mar; 57(3):678-87. PubMed ID: 18057091
[TBL] [Abstract][Full Text] [Related]
24. Secretion of incretin hormones and the insulinotropic effect of gastric inhibitory polypeptide in women with a history of gestational diabetes.
Meier JJ; Gallwitz B; Askenas M; Vollmer K; Deacon CF; Holst JJ; Schmidt WE; Nauck MA
Diabetologia; 2005 Sep; 48(9):1872-81. PubMed ID: 16010522
[TBL] [Abstract][Full Text] [Related]
25. The incretin effect does not differ in trained and untrained, young, healthy men.
Lund MT; Dalby S; Hartmann B; Helge J; Holst JJ; Dela F
Acta Physiol (Oxf); 2014 Mar; 210(3):565-72. PubMed ID: 24354574
[TBL] [Abstract][Full Text] [Related]
26. The pathophysiology of diabetes involves a defective amplification of the late-phase insulin response to glucose by glucose-dependent insulinotropic polypeptide-regardless of etiology and phenotype.
Vilsbøll T; Knop FK; Krarup T; Johansen A; Madsbad S; Larsen S; Hansen T; Pedersen O; Holst JJ
J Clin Endocrinol Metab; 2003 Oct; 88(10):4897-903. PubMed ID: 14557471
[TBL] [Abstract][Full Text] [Related]
27. Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus.
Nauck MA; Heimesaat MM; Orskov C; Holst JJ; Ebert R; Creutzfeldt W
J Clin Invest; 1993 Jan; 91(1):301-7. PubMed ID: 8423228
[TBL] [Abstract][Full Text] [Related]
28. The effect of age and glycemic level on the response of the beta-cell to glucose-dependent insulinotropic polypeptide and peripheral tissue sensitivity to endogenously released insulin.
Meneilly GS; Ryan AS; Minaker KL; Elahi D
J Clin Endocrinol Metab; 1998 Aug; 83(8):2925-32. PubMed ID: 9709971
[TBL] [Abstract][Full Text] [Related]
29. Incretin effect after oral amino acid ingestion in humans.
Lindgren O; Pacini G; Tura A; Holst JJ; Deacon CF; Ahrén B
J Clin Endocrinol Metab; 2015 Mar; 100(3):1172-6. PubMed ID: 25490278
[TBL] [Abstract][Full Text] [Related]
30. The Effect of Melatonin on Incretin Hormones: Results From Experimental and Randomized Clinical Studies.
Lauritzen ES; Støy J; Bæch-Laursen C; Grarup N; Jessen N; Hansen T; Møller N; Hartmann B; Holst JJ; Kampmann U
J Clin Endocrinol Metab; 2021 Nov; 106(12):e5109-e5123. PubMed ID: 34265066
[TBL] [Abstract][Full Text] [Related]
31. Impact of incretin on early-phase insulin secretion and glucose excursion.
Shen J; Chen Z; Chen C; Zhu X; Han Y
Endocrine; 2013 Oct; 44(2):403-10. PubMed ID: 23283820
[TBL] [Abstract][Full Text] [Related]
32. Different mechanisms of GIP and GLP-1 action explain their different therapeutic efficacy in type 2 diabetes.
Grespan E; Giorgino T; Natali A; Ferrannini E; Mari A
Metabolism; 2021 Jan; 114():154415. PubMed ID: 33137379
[TBL] [Abstract][Full Text] [Related]
33. Canagliflozin potentiates GLP-1 secretion and lowers the peak of GIP secretion in rats fed a high-fat high-sucrose diet.
Hira T; Koga T; Sasaki K; Hara H
Biochem Biophys Res Commun; 2017 Oct; 492(2):161-165. PubMed ID: 28803984
[TBL] [Abstract][Full Text] [Related]
34. Postprandial responses of incretin and pancreatic hormones in non-diabetic patients with end-stage renal disease.
Idorn T; Knop FK; Jørgensen M; Holst JJ; Hornum M; Feldt-Rasmussen B
Nephrol Dial Transplant; 2014 Jan; 29(1):119-27. PubMed ID: 24078334
[TBL] [Abstract][Full Text] [Related]
35. Normal secretion of the incretin hormones glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 during gestational diabetes mellitus.
Cypryk K; Vilsbøll T; Nadel I; Smyczyńska J; Holst JJ; Lewiński A
Gynecol Endocrinol; 2007 Jan; 23(1):58-62. PubMed ID: 17484514
[TBL] [Abstract][Full Text] [Related]
36. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
37. Two incretin hormones GLP-1 and GIP: comparison of their actions in insulin secretion and β cell preservation.
Yabe D; Seino Y
Prog Biophys Mol Biol; 2011 Nov; 107(2):248-56. PubMed ID: 21820006
[TBL] [Abstract][Full Text] [Related]
38. Comparative effects of intraduodenal fat and glucose on the gut-incretin axis in healthy males.
Wu T; Rayner CK; Watson LE; Jones KL; Horowitz M; Little TJ
Peptides; 2017 Sep; 95():124-127. PubMed ID: 28800948
[TBL] [Abstract][Full Text] [Related]
39. Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
Meyer-Gerspach AC; Cajacob L; Riva D; Herzog R; Drewe J; Beglinger C; Wölnerhanssen BK
PLoS One; 2016; 11(3):e0150803. PubMed ID: 26942445
[TBL] [Abstract][Full Text] [Related]
40. Administration of an acylated GLP-1 and GIP preparation provides added beneficial glucose-lowering and insulinotropic actions over single incretins in mice with Type 2 diabetes and obesity.
Gault VA; Kerr BD; Harriott P; Flatt PR
Clin Sci (Lond); 2011 Aug; 121(3):107-17. PubMed ID: 21332446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
